Incidence, prognostic value and management of vascular complications with transfemoral transcatheter aortic valve implantation

Future Cardiology

Volumn 7, Issue 3, 2011, Pages 321-331

  Saia, Francesco ^a   Bordoni, Barbara ^a   Marrozzini, Cinzia ^a   Ciuca, Cristina ^a   Moretti, Carolina ^a   Branzi, Angelo ^a   Marzocchi, Antonio ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

aortic valve stenosis; biologic prosthesis; transcatheter; vascular complications

Indexed keywords

ARTERY OCCLUSION; FEMORAL ARTERY OCCLUSION; HUMAN; INCIDENCE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIVASCULAR LEAK; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK FACTOR; STENT; TRANSCATHETER AORTIC VALVE IMPLANTATION; TRANSFEMORAL TRANSCATHETER AORTIC VALVE IMPLANTATION; VASCULAR COMPLICATION; VASCULAR DISEASE;

AGED; AGED, 80 AND OVER; AORTIC VALVE STENOSIS; FEMALE; HEART CATHETERIZATION; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; INCIDENCE; INTRAOPERATIVE COMPLICATIONS; ITALY; PERIOPERATIVE CARE; PREVALENCE; PROGNOSIS; RISK FACTORS;

EID: 79958164219     PISSN: 14796678     EISSN: 17448298     Source Type: Journal    
DOI: 10.2217/fca.11.16     Document Type: Review

References (30)

1. Piazza N, Grube E, Gerckens U, et al. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) Corevalve revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval. EuroIntervention 4, 242-249 (2008).
2. Webb JG, Pasupati S, Humphries K, et al. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation 116, 755-763 (2007). (Pubitemid 47255993)
3. Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N. Engl. J. Med. 363, 1597-1607 (2010).
4. Clavel MA, Webb JG, Rodes-Cabau J, et al. Comparison between transcatheter and surgical prosthetic valve implantation in patients with severe aortic stenosis and reduced left ventricular ejection fraction. Circulation 122, 1928-1936 (2010).
5. Masson JB, Kovac J, Schuler G, et al. Transcatheter aortic valve implantation: review of the nature, management, and avoidance of procedural complications. JACC Cardiovasc. Interv. 2, 811-820 (2009).
6. van Mieghem NM, Nuis RJ, Piazza N, et al. Vascular complications with transcatheter aortic valve implantation using the 18 Fr Medtronic CoreValve System: the Rotterdam experience. EuroIntervention 5, 673-679 (2010).
7. Eltchaninoff H, Prat A, Gilard M, et al. Transcatheter aortic valve implantation: early results of the FRANCE (French Aortic National CoreValve and Edwards) registry. Eur. Heart J. 32, 191-197 (2011).
8. Webb JG, Altwegg L, Boone RH, et al. Transcatheter aortic valve implantation: impact on clinical and valve-related outcomes. Circulation 119, 3009-3016 (2009).
9. Tamburino C, Capodanno D, Ramondo A, et al. Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation 123(3), 299-308 (2011).
10. Leon MB, Piazza N, Nikolsky E, et al. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium. Eur. Heart J. 32(2), 205-217 (2011).
11. Grube E, Buellesfeld L, Mueller R, et al. Progress and current status of percutaneous aortic valve replacement: results of three device generations of the CoreValve Revalving system. Circ. Cardiovasc. Interv. 1, 167-175 (2008).
12. Piper WD, Malenka DJ, Ryan TJ Jr, et al. Predicting vascular complications in percutaneous coronary interventions. Am. Heart J. 145, 1022-1029 (2003). (Pubitemid 36688253)
13. Doyle BJ, Ting HH, Bell MR, et al. Major femoral bleeding complications after percutaneous coronary intervention: incidence, predictors, and impact on long-term survival among 17,901 patients treated at the Mayo Clinic from 1994 to 2005. JACC Cardiovasc. Interv. 1, 202-209 (2008). (Pubitemid 351506552)
14. Patel MR, Jneid H, Derdeyn CP, et al. Arteriotomy closure devices for cardiovascular procedures: a scientific statement from the American Heart Association. Circulation 122, 1882-1893 (2010).
15. Ducrocq G, Francis F, Serfaty JM, et al. Vascular complications of transfemoral aortic valve implantation with the Edwards SAPIEN prosthesis: incidence and impact on outcome. EuroIntervention 5, 666-672 (2010).
16. Himbert D, Descoutures F, Al-Attar N, et al. Results of transfemoral or transapical aortic valve implantation following a uniform assessment in high-risk patients with aortic stenosis. J. Am. Coll. Cardiol. 54, 303-311 (2009).
17. Rodes-Cabau J, Webb JG, Cheung A, et al. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. J. Am. Coll. Cardiol. 55, 1080-1090 (2010).
18. Delgado V, Ewe SH, Ng AC, et al. Multimodality imaging in transcatheter aortic valve implantation: key steps to assess procedural feasibility. EuroIntervention 6, 643-652 (2010).
19. de Jaegere PP, van Dijk LC, van Sambeek MR, et al. How should I treat a patient with severe and symptomatic aortic stenosis who is rejected for surgical and transfemoral valve replacement and in whom a transapical implantation was aborted? Percutaneous reconstruction of the right ilio-femoral tract with balloon angioplasty followed by the implantation of self-expanding stents. EuroIntervention 4, 292-296 (2008).
20. Jilaihawi H, Bonan R, Asgar A, et al. Anatomic suitability for present and next generation transcatheter aortic valve prostheses: evidence for a complementary multidevice approach to treatment. JACC Cardiovasc. Interv. 3, 859-866 (2010).
21. Petronio AS, De Carlo M, Bedogni F, et al. Safety and efficacy of the subclavian approach for transcatheter aortic valve implantation with the CoreValve revalving system. Circ. Cardiovasc. Interv. 3, 359-366 (2010).
22. Walther T, Schuler G, Borger MA, et al. Transapical aortic valve implantation in 100 consecutive patients: comparison to propensity-matched conventional aortic valve replacement. Eur. Heart J. 31, 1398-1403 (2010).
23. Masson JB, Al Bugami S, Webb JG: Endovascular balloon occlusion for catheter-induced large artery perforation in the catheterization laboratory. Catheter Cardiovasc. Interv. 73, 514-518 (2009).
24. Vergnat M, Finet G, Rioufol G, Obadia JF: Percutaneous femoral artery access with Prostar device for innovative mitral and aortic interventions. Eur. J. Cardiothorac. Surg. 39(4), 600-602 (2010).
25. Sharp AS, Michev I, Maisano F, et al. A new technique for vascular access management in transcatheter aortic valve implantation. Catheter Cardiovasc. Interv. 75, 784-793 (2010).
26. Tchetche D, Dumonteil N, Sauguet A, et al. Thirty-day outcome and vascular complications after transarterial aortic valve implantation using both Edwards Sapien and Medtronic CoreValve bioprostheses in a mixed population. EuroIntervention 5, 659-665 (2010).
27. Thomas M, Schymik G, Walther T, et al. Thirty-day results of the SAPIEN aortic Bioprosthesis European Outcome (SOURCE) Registry: a European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation 122, 62-69 (2010).
28. Webb JG, Chandavimol M, Thompson CR, et al. Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation 113, 842-850 (2006).
29. Jilaihawi H, Spyt T, Chin D, Logtens E, Laborde JC, Kovac J: Percutaneous aortic valve replacement in patients with challenging aortoiliofemoral access. Catheter Cardiovasc. Interv. 72, 885-890 (2008).
30. Grube E, Schuler G, Buellesfeld L, et al. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. J. Am. Coll. Cardiol. 50, 69-76 (2007). (Pubitemid 46970878)